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A highly speciﬁc accumulation of the toxic element lead was recently measured
in the transition zone between non-calciﬁed and calciﬁed normal human
articular cartilage. This transition zone, the so-called ‘tidemark’, is considered to
be an active calciﬁcation front of great clinical importance. However, little is
known about the mechanisms of accumulation and the chemical form of Pb in
calciﬁed cartilage and bone. Using spatially resolved X-ray absorption near-edge
structure analysis (m-XANES) at the Pb L3-edge, the chemical state of Pb in the
osteochondral region was investigated. The feasibility of the m-XANES set-up
at the SUL-X beamline (ANKA synchrotron light source) was tested and
conﬁrmed by comparing XANES spectra of bulk Pb-reference compounds
recorded at both the XAS and the SUL-X beamline at ANKA. The m-XANES
set-up was then used to investigate the tidemark region of human bone (two
patella samples and one femoral head sample). The spectra recorded at the
tidemark and at the trabecular bone were found to be highly correlated with the
spectra of synthetic Pb-doped carbonated hydroxyapatite, suggesting that in
both of these very different tissues Pb is incorporated into the hydroxyapatite
structure.
Keywords: X-ray absorption spectroscopy; Pb L3-edge XANES; human bone; tidemark;
trabecular bone.
1. Introduction
Exposure to the toxic element lead is associated with chronic
diseases of the nervous, hematopoietic, skeletal, renal and
endocrine systems (Ja ¨rup, 2003). Pb is predominantly stored in
the human skeleton, where approximately 95% of the total
body burden is present (Wittmers et al., 1988). Bone is a
composite material consisting of an organic component of the
matrix, which is predominantly of type-I collagen molecules,
which assemble in a regularly staggered manner to form ﬁbrils
of several hundred nanometres diameter. These collagen
ﬁbrils are impregnated with and surrounded by small nano-
crystallite particles of carbonated apatite (Fratzl et al., 2004).
The tibia and patella have been widely used in epidemio-
logic studies to determine bone Pb levels by in vivo K-line
X-ray ﬂuorescence (XRF). However, owing to the large
information depth ( 2 cm) when considering Pb K-lines
(75 keV photons) in in vivo XRFanalysis, signals are detected
from a large bone volume and lack spatial resolution.
In recent studies we investigated the spatial distribution of
Pb in the osteochondral region of normal human joints
(Zoeger et al., 2006, 2008) using Pb L ﬂuorescence lines(10.55 keV photons). The osteochondral unit has a highly
complex structure, which is designed to ensure a frictionless
movement in articulating joints and to transfer loads from
articular cartilage to underlying bone tissue. It is basically
composed of articular cartilage, calciﬁed cartilage and
subchondral bone (Wong & Carter, 2003). The zone of calci-
ﬁed cartilage is about 100 mm thick and provides the tight
bonding of articular cartilage to subchondral bone.
Using synchrotron-radiation-based micro-X-ray ﬂuores-
cence analysis (m-XRF) in confocal geometry we could show
a highly speciﬁc accumulation of Pb in the transition zone
between calciﬁed and non-calciﬁed articular cartilage, the so-
called ‘tidemark’ (Zoeger et al., 2006, 2008). Pb levels in the
tidemark were approximately 13-fold higher than in the
subchondral and trabecular bone. The tidemark is considered
to be a metabolically active mineralization front (Lemperg,
1971). However, very little is known about the process of
mineralization in this region and even less about the
mechanism of Pb accumulation. Moreover, surprisingly little
is known about the chemical species of Pb even in calciﬁed
articular cartilage. Articular cartilage is predominantly type-II
collagen and a non-collagenous matrix consisting mainly of
proteoglycans and water as well as poorly crystalline
hydroxyapatite in the calciﬁed cartilage region (Maroudas,
1979). A major component of proteoglycans is sulfur in the
form of sulfate, binding large amounts of water to the cartilage
tissue. Since the content of proteoglycan is not uniform, sulfur
is also not homogeneously distributed in articular cartilage.
The sulfur content reaches its maximum adjacent to the
tidemark where it rapidly drops off (Reinert et al., 2002). As
Pb is a chalcogenic element, Pb is most likely bound to SH
groups in bone areas showing high sulfur concentrations.
However, the fact that sulfur reaches its maximum adjacent to
the tidemark where it rapidly drops off suggests another
mechanism of Pb incorporation into calciﬁed bone. Calcium
hydroxyapatite (CaHA) is known for its facile ion-exchange
properties, playing a multifaceted role mainly in environ-
mental and chemical applications (Ellis et al., 2006; Chartier et
al., 2001; Ma et al., 1993; Mavropoulos et al., 2002; Meis et al.,
2000; Park et al., 2002; Xu & Schwartz, 1994). CaHA has the
ability to trap and store toxic heavy metals by replacing Ca
2+
ions in hydroxyapatite with metal ions, for instance lead,
cadmium copper or zinc. This mechanism is successfully used
for in situ immobilization and remediation of toxic heavy
metals in contaminated soil from landﬁlls and contaminated
ground- and waste water (Chaturvedi et al., 2006; Ma, 1996;
Ma et al., 1994; Takeuchi & Arai, 1990). Therefore, the
replacement of Ca ions in hydroxyapatite with Pb seems to be
the most likely mechanism of binding lead in the calciﬁed
cartilage region. However, the different chemical composition
of articular cartilage (e.g. high S content dropping off at the
tidemark) could allow for the presence of various Pb
compounds, such as sulfates, sulﬁdes, carbonates and oxides.
To determine the species of Pb in the tidemark and bone we
applied spatially resolved X-ray absorption spectroscopy
(XAS) (Koningsberger & Prins, 1987; Sto ¨hr,1992; Proost et al.,
2003) at the L3 absorption edge of Pb (13.035 keV). The X-ray
absorption near-edge structure (XANES) spectra were
compared with those of various reference compounds. Spatial
resolved (m)-XANES measurements have been performed at
the X-ray beamline of the Synchrotron Radiation Laboratory
for Environmental Studies (SUL-X) of the synchrotron
radiation source ANKA (Institute for Synchrotron Radiation,
Karlsruhe Institute of Technology, Germany). Additionally,
some reference compounds were analysed at the XAS
beamline (unfocused beam) at ANKA conﬁrming the relia-
bility of the m-XANES measurements.
2. Materials and methods
2.1. Bone samples
In this study two human patella samples previously inves-
tigated by confocal m-XRF (Zoeger et al., 2006, 2008) and
one additional femoral head sample were analyzed using
m-XANES spectroscopy (Table 1). The samples were taken
from randomly selected forensic autopsies of patients who
died of an acute illness with no history of metabolic bone
disease or Pb exposure. The selected samples showed no
macroscopic signs of osteoarthritis. The study was approved
by the Institutional Ethical Review Board of the Medical
University of Vienna, Vienna, Austria. A 5 mm-thick section
was cut perpendicular to the articular surface from the central
region of the patella (sagittal plane). The sample was ﬁxed in
70% ethanol, dehydrated through a series of alcohols, and
embedded in polymethylmethacrylate (PMMA). The surfaces
of the PMMA block were polished with diamond suspension
and carbon coated for backscattered electron imaging (qBEI)
as described previously (Roschger et al., 1995, 1998). Sample
slices of thickness 200 mm containing the bone area previously
analyzed by qBEI imaging (see Fig. 1) were cut using a low-
speed diamond saw (Buehler Isomed, Lake Pluff, USA).
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Table 1
Measured bone samples and reference materials.
Sample Tidemark Trabecular bone
Human patella k3807 k3807_Pos1 Not measured
k3807_Pos2
k3807_Pos3
Human patella G3776 G3776_TM1 G3776_TBR1
G3776_TM2 G3776_TBR2
G3776_TBR3
Human femoral head A3753 A3753_TM1 A3753_TBR1
Reference materials
PbCO3 Pb(OH)2
PbSO4 PbCO3 Pb(OH)2
PbO Pb-HA_1 (400 mgg
 1 Pb)
PbS Pb-HA_2 (700 mgg
 1 Pb)
PbCl2 Pb-HA_3 (1200 mgg
 1 Pb)
Pb(NO3)2 Pb-HA (303 mgg
 1 Pb)
PbO2 Pb-CHA (335 mgg
 1 Pb)2.2. Reference samples
Fourteen different Pb reference compounds have been
investigated as being possible candidates for Pb compounds
in bone: PbCO3 (Merck), PbSO4, PbO, PbO2, PbCl2,
PbCO3 Pb(OH)2 (Fluka Chemie AG), PbS (Alfa Aesar),
Pb(NO3)2, Pb(OH)2 as well as synthetic Pb-doped HA
(hydroxyapatite) and CHA (carbonated hydroxyapatite)
(Tabel 1). All reference materials were milled, mixed with
polyethylene (Uvasol, Merck) or cellulose and pressed into
pellets (pressure: 36.95   10
5 Pa; time: 5 min). The HA
powder standards were pressed with no additive, except Pb-
HA 303 mgg
 1 Pb, where 23% cellulose had been added.
The synthesis of Pb-substituted HA powders was carried
out by neutralization of a calcium hydroxide suspension
[Ca(OH)2] with an orthophosphoric acid solution (H3PO4)
and adding lead nitrate [Pb(NO3)2] in the basic suspension in
different amounts. In this way lead-substituted HA can be
obtained, covering the entire range of substitution (Bigi et al.,
1989; Bru ¨ckner et al., 1995), where Pb replaces Ca in both
octahedral and tetrahedral sites.
In order to assess whether the neutralization method
allowed partially substituted HA to be obtained without any
secondary phases containing lead, a synthesis of HA powder
was performed, introducing 20 mol% of Pb, so to clearly put in
evidence both the formation of secondary phases and the cell
distortion owing to the substitution of calcium with lead.
X-ray diffraction analysis showed that the grown HA phase
did not contain any additional phase; the analysis of element
concentration, carried out on the Pb-HA powder by scanning-
electron-microscope energy-dispersive spectroscopy (SEM-
EDS), conﬁrmed the presence of Pb in the product. The
substitution of Ca with Pb (in the synthesis procedure with
20 mol% Pb) was also conﬁrmed by Rietveld analysis, carried
out using TOPAS4.2 software, conﬁrming the distortion of the
hexagonal HA cell. In fact, the crystallographic axes of the
HA cell are: a = 9.422 A ˚ and c = 6.881 A ˚ , and, in Pb-substi-
tuted HA, 9.545 A ˚ and 6.934 A ˚ , respectively. The increase in
the lattice parameters is due to the replacement of Ca by the
larger Pb ion.
The products of the HA syntheses were analyzed by
inductively coupled plasma mass spectrometry (ICP-MS). The
results are given in Table 2. All analyses show Pb in the HA
powders; however, only a fraction of the introduced lead
content was found in the products, while the rest was elimi-
nated through washing out unreacted Pb(NO3)2 starting
material. Details of the preparation of the synthetic Pb-doped
HA references substances can be found in the supplementary
material.
1
2.3. Pb L3-edge XANES
XANES spectra are recorded by tuning the energy of
incident X-ray photons across an absorption edge of a speciﬁc
element present in the sample (here, Pb at the L3-edge). The
XANES contains information about the chemical state of the
absorbing element. One common method (ﬁngerprinting) is to
compare spectra of unknown samples (here, tidemark and
subchondral bone) with those of reference compounds. Bulk
XAS methods can be extended to m-XANES (Proost et al.,
2003) providing spatial resolutions in the micrometre range.
Therefore, m-XANES spectroscopy enables spatial determi-
nation of chemical species (e.g. to distinguish the species of Pb
between tidemark and subchondral bone). In this study,
recording full maps of chemical bindings was not feasible
owing to the samples’ low Pb concentrations of about 5 mgg
 1
(Rosen et al., 1993) to 10 mgg
 1 (Somervaille et al., 1985),
causing extremely long measuring times for area scans. Hence,
Pb L3-edge XANES spectra have been recorded at several
representative points on the sample, selected from the results
of Pb L emission line scans.
Pb L3-edge XANES spectra of the bone samples and
references listed in Table 1 were recorded at the SUL-X
beamline in ﬂuorescence mode. The synthetic Pb-HA samples
were also measured at the ANKA-XAS beamline in ﬂuores-
cence mode to compare the data quality of both beamlines for
spectra from samples with low Pb concentrations.
The X-ray source of SUL-X is a 27-pole wiggler operating at
K = 8.5 (wiggler gap, 16 mm). A silicon (111) crystal pair with
a ﬁxed beam exit was used as monochromator. The X-ray
beam was aligned with an intermediate focus, and ﬁnally
focused by Kirkpatrick–Baez mirrors to about 100 mm (hori-
zontal)   20 mm (vertical) for measurements at the tidemark
and to about 200 mm (horizontal)   150 mm (vertical) for data
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Table 2
Chemical analysis of Pb-substituted HA powders.
Expected molar
Pb/Ca
Actual molar
Pb/Ca
Pb content
(mgg
 1)
Pb-HA_1 0.001 0.0004 400
Pb-HA_2 0.005 0.0035 700
Pb-HA_3 0.01 0.0077 1200
Pb-HA 0.0005 0.0002 303
Pb-CHA 0.0005 0.0002 335
Figure 1
Backscattered electron image of human patella sample G3776. Articular
cartilage (1), tidemark (2), calciﬁed cartilage (3), subchondral bone (4),
cement lines (5).
1 Supplementary data for this paper are available from the IUCr electronic
archives (Reference: HF5181). Services for accessing these data are described
at the back of the journal.acquisition in the trabecular bone. A linear scan across the
calciﬁcation front of the bone sample was performed to
determine the exact position for the XANES measurements at
the tidemark. The Pb L ﬂuorescence intensity was evaluated
for each step of the scan to ﬁnd the maximum intensity which
is known to coincide with the tidemark (Zoeger et al., 2006,
2008). Fig. 2 shows an optical micrograph of the analyzed
patella (sample G3776; below) and the Pb L ﬂuorescence
intensity (above) recorded along the horizontal dashed red
line. The marker TM1 indicates the positions where XANES
scans were performed.
The ﬂuorescence radiation was collected using a seven-
element Si(Li) solid-state detector (Gresham, now e2v) and a
digital signal-processing system (DXP) from XIA.
Three to nine scans were collected for both sample and
reference substances. An energy calibration was performed
and monitored using a Pb foil at the L3-edge in transmission
mode.
The X-ray source of the ANKA XAS beamline is a 1.5 T
bending magnet. The ﬁxed-exit monochromator of the XAS
beamline was operated in step-by-step mode using the Si h111i
crystal pair. A ﬁve-element Ge solid-state detector (Canberra)
was used to collect the ﬂuorescence signal. At least two
spectra for each reference sample were recorded. Similar to
the SUL-X beamline the correctness of the energy calibration
was monitored using a Pb foil at the L3-edge in transmission.
No signiﬁcant change could be detected.
For more details see the supplementary material.
2.4. XANES data analysis
The absorption spectra were recorded summing all ﬂuor-
escence emission counts within the Pb L region of interest.
The resulting XANES spectra were analyzed using ATHENA,
which is included in the IFEFFIT
package for XAS analysis (Newville,
2001; Ravel & Newville, 2005; Newville,
2009). Each scan was normalized to an
edge jump of unity and its energy scale
was corrected with respect to the Pb L3-
edge. Repetitive scans have been
merged together to improve the signal-
to-noise ratio.
3. Results
3.1. XANES spectra of Pb references
The XANES spectra of the three Pb-
HA reference compounds showing
different Pb concentrations measured at
the SUL-X and ANKA XAS beamlines
are displayed in Fig. 3. Both beamlines
produced identical results. At SUL-X
the beam size at the sample position was
about 200 mm (horizontal)   150 mm
(vertical) and at ANKA XAS 7 mm
(horizontal)   1 mm (vertical). The
photon ﬂux per 100 mm   100 mm area on the sample at
13 keV was about 1   10
11 photons s
 1 at SUL-X and about
7.5   10
7 photonss
 1 at XAS.The photon ﬂux at the sample at
the SUL-X beamline was only slightly higher (about 3  
10
11 photons s
 1) than at the ANKA XAS beamline (4  
10
10 photons s
 1), explaining the similar quality of the spectra
for both beamlines.
3.2. XANES spectra of Pb in bone
The XANES spectra recorded at three different positions
(500 mm apart) at the tidemark (TM) of patella sample k3807
(data not shown), obtained at SUL-X, showed no differences
in their features. The same result was obtained for different
positions at the tidemark of patella sample G3776 and femoral
head A3753. Moreover, there were no differences in the
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Figure 2
Pb L3 ﬂuorescence intensities of a line scan across the tidemark of the bone sample G3776
correlated with the reﬂected light micrograph of the sample surface. The positions TM1 indicate the
positions where XANES scans were performed [spot size, 150 mm (horizontal)   100 mm (vertical)].
Figure 3
Comparison of the XANES spectra recorded for the Pb-HA reference
compounds with different concentrations of Pb measured at the SUL-X
and ANKA XAS beamlines.spectra between tidemark and trabecular bone position.
Hence, all spectra from the bone samples have been merged
to obtain a better signal-to-noise ratio for comparison with
spectra of reference materials (Fig. 4).
3.3. Comparison of XANES spectra: tidemark/bone versus
reference
XANES spectra of the measured Pb reference compounds,
including the synthetic Pb-HAs, are compared with the
merged bone XANES spectrum in Fig. 5. It can be seen that
spectra of ﬁve reference substances show similarities with
the XANES recorded for bone. These are PbCO3 Pb(OH)2,
Pb(OH)2, PbS, Pb-HA and Pb-CHA. For better clarity these
spectra are displayed separately in Fig. 6.
The best agreement with the XANES spectra from the bone
samples was found for the synthetic Pb-substituted carbonated
hydroxyapatite (Pb-CHA). These two XANES spectra are
displayed in Fig. 7 along with their difference spectra. The
residual sum of squares of the difference is about 0.01, proving
the excellent match of the Pb-CHA reference material with
the bone data.
4. Discussion
This study demonstrates that the spatial resolved m-XANES
technique on the SUL-X beamline is well suited to allocate the
chemical form of Pb, present in only low concentrations in
human bone and calciﬁed articular cartilage tissue.
The feasibility of m-XANES measurements at the Pb L3-
edge of samples showing low Pb concentrations using the
SUL-X beamline could be afﬁrmed by comparing spectra from
synthetic Pb reference compounds recorded at the SUL-X
and the ANKA XAS beamlines, respectively. This is worth
mentioning because the Pb concentrations in these reference
compounds were rather low ( 300–1200 mgg
 1 Pb; see
Table 2). Although the number of photons hitting the sample
area is slightly higher at the SUL-X beamline than at the
ANKA XAS beamline it was not expected that the quality of
the spectra of the SUL-X beamline would be equal or even
slightly better. The higher ﬂux of the SUL-X beamline seems
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Figure 6
Comparison of best-ﬁtting reference XANES spectra with a merge of all
XANES spectra recorded for the different bone samples (Bone). The
synthetic hydroxiapatite reference Pb-CHA has higher carbon content
than the synthetic hydroxiapatite reference Pb-HA.
Figure 7
Pb L3-edge XANES spectra of merged tidemark/bone (Bone) spectra
and synthetic carbonated Pb-CHA. The bottom (dotted red) line shows
the difference between the two XANES spectra.
Figure 4
Comparison of XANES spectra of tidemark (TM) and trabecular bone
(TBR) positions: A3753 femoral head, G3776 patella. The spectra are
displaced vertically for clarity.
Figure 5
Pb L3-edge XANES spectra for all reference substances of this study
compared with the merged XANES spectrum of all three bone samples
(Bone).to compensate for better averaging on the sample and being
less sensitive to ﬂuctuation of intensity and beam positions of
the non-focusing optics at the ANKA-XAS beamline. The
experimental results proved the competitive capability of the
SUL-X m-XANES set-up in comparison with a beamline
dedicated to bulk XAS and assured the quality of the data
from bone samples. The variations found in the XANES of
reference compounds with Pb in different chemical environ-
ment demonstrated its sensitivity to allocate the chemical state
of Pb in the samples.
The m-XANES spectra recorded at different positions of the
tidemark of both samples showed no differences, indicating
that Pb is generally in the same chemical state at the tidemark
of bone. However, it is most striking that no differences in the
m-XANES spectra between tidemark (calciﬁcation front) and
trabecular bone region could be found, though the chemical
environment/composition between both tissue regions are
known to be very different (Kuhlman, 1980). No other inter-
mediate mechanisms of binding seem to take place at the
calciﬁcation front of articular cartilage. The comparison of the
m-XANES spectra of bone with that of the reference
compounds suggests that Pb is incorporated into bone by
replacing Ca
2+ ions in HA as found in bone and tidemark.
The substitution of Pb in CaHA is a well known mechanism
in the ﬁelds of biochemistry and environmental science, where
synthetic HA is successfully applied in remediation of heavy-
metal-contaminated soil, water or waste (Chaturvedi et al.,
2006). Besides lead, metal substitution on the Ca site involves,
for example, the biological important iron, copper, zinc and
cadmium. The Pb
2+ in solution exchanges with Ca, causing
morphological changes in the surface region. In the case of
high Pb concentrations the formation of Pb-substituted CaHA
is followed by the formation of the pyromorphite phase, where
all Ca is replaced with lead (Ma et al., 1993; Xu & Schwartz,
1994). Currently, four possible immobilization routines
including the ion exchange process, surface complexation,
dissolution and precipitation and co-precipitation have been
generally suggested for the Pb immobilization mechanism of
HA (Ellis et al., 2006).
The mechanism of lead substitution in the apatite structure
has been studied at high Pb concentrations. According to Bigi
et al. (1989) and Bru ¨ckner et al. (1995) it can be assumed that
the same is true for very low Pb concentrations (for example,
in the Pb-doped synthetic apatites and in the bones samples).
Therefore, it can be excluded that separate Pb-containing
phases are present, leading to the conclusion that Pb in bones
is in fact incorporated into the apatite structure.
Among the investigated Pb reference compounds, Pb-CHA
was found to ﬁt best to the spectra recorded at tidemarks and
trabecular bone tissue. This is in agreement with the fact that
carbonate substitution occurs at both hydroxyl and phosphate
sites, and, along with Ca-deﬁcient HA, plays an important role
in the nanocrystalline structure of bone tissue (Ellis et al.,
2006). Bone is a composite material containing mineral
nanocrystallites and a protein matrix that is predominantly
cross-linked type-I collagen. Previous studies have shown that
the mineral is a carbonated calcium phosphate within the
apatite crystalline structure group. Moreover, bone is unique
in comparison with the geological apatite HA in that carbo-
nate substitutes for about 68% of the phosphate and relatively
little hydroxide is present (20% or less) (Awonusi et al., 2007;
Cho et al., 2003; Pasteris et al., 2004).
The tiny differences observed in m-XANES between tide-
mark/bone and the Pb-CHA reference right above the
absorption edge suggest either that still a very small fraction
of Pb is present in an unknown state or that the carbon
concentration in the HA reference material does not perfectly
match the carbon content in human bone material.
While most of the health hazards of lead are well known
(Ja ¨rup, 2003), the effects of Pb on cartilagemetabolism are less
well studied. Chondrozytes seem to be important target cells
for the toxic effects of Pb (Puzas et al., 1992). Intra-articular
lead has been shown to lead to osteoarthritic changes in the
knee joint in humans (Slavin et al., 1988) as well as in
experimental animal models (Harding et al., 1999; Bolanos et
al., 1995). Moreover, it was shown in an experimental mouse
model that exposure to lead inhibits fracture healing. It was
possible to show that Pb exposure leads to an increased
cartilage formation with delayed maturation and calciﬁcation
and increased formation of ﬁbrous tissue during bone repair
(Carmouche et al., 2005). However, at this stage, it is still
unclear what the medical consequences of Pb accumulation in
the tidemark region are.
In conclusion, the m-XANES set-up at the SUL-X beamline
at ANKA has proven to be well suited for the determination
of the species of lead in human bone and cartilage samples.
The outcome, that Pb is bound to carbonated hydroxyapatite
in the tidemark, sheds new light onto the speciﬁc accumulation
on Pb in this sensitive articular joint. Previously suggested
mechanisms for immobilization of Pb in HA (Ellis et al., 2006)
may be involved in the incorporation of lead into calciﬁed
bone tissue and the tidemark.
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